Evidence map›Paper›PMID 36684874›Full record

ArticleFrontiers in public health2022

The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.

Sondes Haddad-Boubaker, Marwa Arbi, Oussema Souiai, Anissa Chouikha, Wasfi Fares, Kate Edington, Sam Sims, Cesare Camma, Alessio Lorusso, Moussa Moïse Diagne and 24 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 10 institutions in 4 countries.

Sondes Haddad-BoubakerLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Marwa ArbiLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Oussema SouiaiLaboratory of Bioinformatics, Biomathematics and Biostatistics, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Anissa ChouikhaLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Wasfi FaresLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Kate EdingtonNew Variant Assessment Platform (NVAP), UK Health Security Agency, London, United Kingdom.
Sam SimsNew Variant Assessment Platform (NVAP), UK Health Security Agency, London, United Kingdom.
Cesare CammaDepartment of Virology, Instituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise G. Caporale (IZSAM), Teramo, Italy.
Alessio LorussoDepartment of Virology, Instituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise G. Caporale (IZSAM), Teramo, Italy.
Moussa Moïse DiagneDepartment of Virology, Pasteur Institute of Dakar, Dakar, Senegal.
Amadou DialloDepartment of Virology, Pasteur Institute of Dakar, Dakar, Senegal.
Ilhem Boutiba Ben BoubakerLaboratory of Microbiology, Charles Nicolle Hospital, Tunis, Tunisia.
Sana FerjaniLaboratory of Microbiology, Charles Nicolle Hospital, Tunis, Tunisia.
Maha MastouriLaboratory of Microbiology, Fattouma Bourguiba Hospital, Monastir, Tunisia.
Salma MhallaLaboratory of Microbiology, Fattouma Bourguiba Hospital, Monastir, Tunisia.
Hela KarrayLaboratory of Microbiology, Habib Bourguiba Hospital, Sfax, Tunisia.
Saba GargouriLaboratory of Microbiology, Habib Bourguiba Hospital, Sfax, Tunisia.
Olfa BahriLaboratory of Microbiology and Biochemistry, Aziza Othmana Hospital, Tunis, Tunisia.
Abdelhalim TrabelsiLaboratory of Virology, Sahloul Hospital of Sousse, Sousse, Tunisia.
Ouafa KallalaLaboratory of Virology, Sahloul Hospital of Sousse, Sousse, Tunisia.
Naila HannachiLaboratory of Microbiology, Farhat Hached Hospital of Sousse, Sousse, Tunisia.
Yassine ChaabouniLaboratory of Medical Biology, Ibn El Jazzar Hospital, Kairouan, Tunisia.
Hanen SmaouiDepartment of Microbiology, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Khaoula MeftahDepartment of Microbiology, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Sophia Besbes BouhalilaLaboratory of Medical Biology and Blood Bank, Institute Mohamed Kassab d'orthopédie, Manouba, Tunisia.
Soumaya FoughaliLaboratory of Medical Biology, Menzel Bourguiba Hospital, Bizerte, Tunisia.
Mariem ZribiLaboratory of Microbiology, La Rabta Hospital, Tunis, Tunisia.
Asma LamariLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Henda TouziLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Mouna SaferNational Observatory of New and Emergent Diseases, Tunis, Tunisia.
Nissaf Ben AlayaDepartment of Microbiology, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Alia Ben KahlaLaboratory of Bioinformatics, Biomathematics and Biostatistics, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Mariem GdouraLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Henda TrikiLaboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institute Pasteur de Tunis, University of Tunis El-Manar, Tunis, Tunisia.
Tunis University · TNHôpital Sahloul · TNHopital Universitaire Habib Bourguiba · TNInstitut Pasteur de Dakar · SNIstituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise G. Caporale · ITUK Health Security Agency · GBUniversity of Monastir · TNHôpital Farhat Hached · TNHôpital La Rabta · TNManouba University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Delta variant posed an increased risk to global public health and rapidly replaced the pre-existent variants worldwide. In this study, the genetic diversity and the spatio-temporal dynamics of 662 SARS-CoV2 genomes obtained during the Delta wave across Tunisia were investigated. Methods: Viral whole genome and partial S-segment sequencing was performed using Illumina and Sanger platforms, respectively and lineage assignemnt was assessed using Pangolin version 1.2.4 and scorpio version 3.4.X. Phylogenetic and phylogeographic analyses were achieved using IQ-Tree and Beast programs. Results: The age distribution of the infected cases showed a large peak between 25 to 50 years. Twelve Delta sub-lineages were detected nation-wide with AY.122 being the predominant variant representing 94.6% of sequences. AY.122 sequences were highly related and shared the amino-acid change ORF1a:A498V, the synonymous mutations 2746T>C, 3037C>T, 8986C>T, 11332A>G in ORF1a and 23683C>T in the S gene with respect to the Wuhan reference genome (NC_045512.2). Spatio-temporal analysis indicates that the larger cities of Nabeul, Tunis and Kairouan constituted epicenters for the AY.122 sub-lineage and subsequent dispersion to the rest of the country. Discussion: This study adds more knowledge about the Delta variant and sub-variants distribution worldwide by documenting genomic and epidemiological data from Tunisia, a North African region. Such results may be helpful to the understanding of future COVID-19 waves and variants.

Indexed as

COVID-19Genetic VariationSARS-CoV-2AdultAnimalsHumansMiddle AgedPangolinsPhylogenyRNA, ViralTunisiaRNA, ViralAY.122Delta variantnext-generation sequencingphylogenySARS-CoV2spatio-temporal dynamic

Identifiers

PMID36684874
PMCPMC9846204
OpenAlexW4313584226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.